Expanded Emergency Use Authorization Archives

FDA expands emergency use of Gilead’s remdesivir in hospitalized Covid-19 patients

Antivirals, Data, Emergency Use Authorization, Expanded Emergency Use Authorization, FDA, FDA/Regulatory, Hospitalized COVID-19 Patients, Remdesivir, Studies

The U.S. Food and Drug Administration expanded the emergency use authorization of Gilead Inc.’s experimental antiviral Covid-19 treatment remdesivir to allow the product’s use in all hospitalized Covid-19 patients.

August 28, 2020/by Andrew Humphreys